ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer
home / peer-exchange / elcc-updates-in-immunotherapy-and-beyond-for-non-small-cell-lung-cancer
Sponsored in part by Regeneron. Content independently created by OncLive.
A panel of experts discuss updates in immunotherapy for advanced non-small cell lung cancer (NSCLC) and the impact of recent clinical trial data on treatment decision-making.